Vanguard Portfolio Management »

Monopar Therapeutics shares owned by Vanguard Portfolio Management

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Vanguard Portfolio Management from 13F filings

Historical chart of Vanguard Portfolio Management investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Vanguard Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Vanguard Portfolio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5M 46k 54.79